Increasing access to mifepristone
Gynuity Health Projects
Award amount: $108,277
Paving the way for registration and commercialization for additional indications (New and Underused Reproductive Health Technologies Caucus). Gynuity Health Projects will support efforts to register mifepristone at country level by emphasizing its wider role as a women’s health medication, administered by providers who both do and do not offer abortion services. More indications, it is hoped, will increase sales and thus market sustainability, which could in turn generate interest from the private sector.
Expanding Consumer Access to RH Supplies in an e-Commerce Age
Institute for Reproductive Health/Georgetown University: Expanding Consumer Access to RH Supplies in an e-Commerce Age: Promise and Perils for the Future
Award amount: $ 197,826
IRH will explore the current context and future implications of RH supplies in an e-commerce age, highlighting both the opportunities and challenges that lie ahead. Through a landscaping analysis, IRH will create a conceptual framework for considering the implications of purchasing supplies in the digital marketplace and produce evidence-based case studies and an analytical report on the e-commerce landscape within three countries (Kenya, India, and Mexico) and across three commodities (CycleBeads, female condom, and emergency contraception). Partners on the grant include Cycle Technologies, the International Consortium for Emergency Contraception, Rutgers, Mexfam, and iHub Research.
Assessing the Availability of Pregnancy Tests
FHI 360: Crossing Over the Thin Blue Line: Assessing the Availability of Pregnancy Tests
Award amount: $127,660
FHI 360, in conjunction with Marie Stopes International, will conduct a ten-month landscaping exercise in three African countries to better understand the current availability, affordability, and quality of pregnancy tests. The objectives are to:
- conduct country-level data collection and analysis in Mali, Malawi, and Kenya;
- engage stakeholders in-country to share data and issue recommendations/final report;
- develop evidence-based clinical guidance for healthcare providers and advocacy tools for global stakeholders on the appropriate usage of the Pregnancy Checklist versus pregnancy tests.
Identifying Gaps in National Essential Medicines Lists
Family Care International/International Consortium for Emergency Contraception: Identifying Gaps in National Essential Medicines Lists: Laying the Groundwork for Expanded Access to New and Underutilized RH Technologies
Award amount: $46,016
The project aims to document inclusion of the 13 priority NURHT products in national Essential Medicines Lists (EML), disseminate information widely to country partners to provide needed data to support efforts to update EMLs, and raise awareness and engagement around the issue of EMLs. The output of this work will be a dynamic and searchable compendium, highlighting countries with gaps related to new and underused commodities and paving the way for country-level advocacy efforts to address these gaps.
Interested in applying for a grant?